ChemPartner PharmaTech Co Ltd (300149) — Financial Flexibility Index
ChemPartner PharmaTech Co Ltd (300149) has a Financial Flexibility Index of 0.09x as of June 2023. Free cash flow of CN¥94.83 Million (operating CF CN¥28.21 Million minus capex CN¥66.62 Million) represents 0% of total liabilities (CN¥1.06 Billion). Check ChemPartner PharmaTech Co Ltd strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ChemPartner PharmaTech Co Ltd Financial Flexibility Index (2007–2025)
Historical Financial Flexibility Index trend for ChemPartner PharmaTech Co Ltd across 19 annual periods. See working capital to net assets of ChemPartner PharmaTech Co Ltd to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for ChemPartner PharmaTech Co Ltd (2007–2025)
Year-by-year free cash flow to debt coverage for ChemPartner PharmaTech Co Ltd. For the full company profile including market capitalisation, see 300149 market cap.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.35x | CN¥252.97 Million | CN¥190.50 Million | CN¥732.59 Million | ▲ +10.2% |
| 2024 | 0.31x | CN¥237.45 Million | CN¥168.21 Million | CN¥757.75 Million | ▼ -13.4% |
| 2023 | 0.36x | CN¥352.28 Million | CN¥150.99 Million | CN¥973.44 Million | ▼ -13.1% |
| 2022 | 0.42x | CN¥598.66 Million | CN¥262.46 Million | CN¥1.44 Billion | ▲ +39.7% |
| 2021 | 0.30x | CN¥664.22 Million | CN¥378.22 Million | CN¥2.23 Billion | ▼ -32.5% |
| 2020 | 0.44x | CN¥737.19 Million | CN¥343.16 Million | CN¥1.67 Billion | ▲ +37.8% |
| 2019 | 0.32x | CN¥469.30 Million | CN¥215.07 Million | CN¥1.46 Billion | ▲ +3.8% |
| 2018 | 0.31x | CN¥353.07 Million | CN¥243.19 Million | CN¥1.14 Billion | ▼ -5.2% |
| 2017 | 0.33x | CN¥67.65 Million | CN¥63.43 Million | CN¥207.73 Million | ▼ -90.7% |
| 2016 | 3.52x | CN¥81.71 Million | CN¥71.26 Million | CN¥23.23 Million | ▼ -10.2% |
| 2015 | 3.91x | CN¥126.02 Million | CN¥100.69 Million | CN¥32.19 Million | ▲ +27.8% |
| 2014 | 3.06x | CN¥136.56 Million | CN¥59.63 Million | CN¥44.60 Million | ▼ -5.8% |
| 2013 | 3.25x | CN¥109.50 Million | CN¥46.32 Million | CN¥33.70 Million | ▼ -51.8% |
| 2012 | 6.74x | CN¥180.00 Million | CN¥55.09 Million | CN¥26.72 Million | ▲ +360.5% |
| 2011 | 1.46x | CN¥32.73 Million | CN¥11.66 Million | CN¥22.37 Million | ▼ -37.4% |
| 2010 | 2.34x | CN¥37.70 Million | CN¥20.81 Million | CN¥16.12 Million | ▲ +155.2% |
| 2009 | 0.92x | CN¥32.11 Million | CN¥13.28 Million | CN¥35.04 Million | ▼ -43.1% |
| 2008 | 1.61x | CN¥46.03 Million | CN¥21.70 Million | CN¥28.57 Million | ▲ +144.9% |
| 2007 | 0.66x | CN¥28.64 Million | CN¥22.19 Million | CN¥43.53 Million | — |